grant

Post-Translational Modification of Annexin A2 Mediates Surfactant Dysfunction During Injurious Mechanical Ventilation

Organization OHIO STATE UNIVERSITYLocation Columbus, UNITED STATESPosted 1 Dec 2024Deadline 30 Nov 2026
NIHUS FederalResearch GrantFY2026ARDSActinsAcute Lung InjuryAcute Pulmonary InjuryAcute Respiratory DistressAcute Respiratory Distress SyndromeAdult ARDSAdult RDSAdult Respiratory Distress SyndromeAffectAirway failureAlveolarAlveolusAnnexinsAwardBacterial PneumoniaBarotraumaBindingBinding ProteinsBronchial AlveolusBundlingC-terminal Src kinaseCOVID crisisCOVID epidemicCOVID pandemicCOVID-19 crisisCOVID-19 epidemicCOVID-19 eraCOVID-19 global health crisisCOVID-19 global pandemicCOVID-19 health crisisCOVID-19 pandemicCOVID-19 periodCOVID-19 public health crisisCOVID-19 yearsCSK Protein KinaseCSK-srcCalcimedinsCell BodyCell Culture TechniquesCell IsolationCell SegregationCell SeparationCell Separation TechnologyCell membraneCell-Free SystemCellfree SystemCellsClinicalCritical IllnessCritically IllCytoplasmic MembraneDa Nang LungDataDeath RateDevicesDysbarismDysfunctionEducational workshopEpithelial CellsFoundationsFunctional disorderGene ModifiedGenerationsGoalsGrantHumanImpairmentInflammatoryInjuryInvestigatorsKinasesLamellar BodyLeadLifeLigand Binding ProteinLigand Binding Protein GeneLipocortinsLungLung Respiratory SystemLung SurfactantLung damageManuscriptsMeasuresMechanical ventilationMediatingMentorshipMiceMice MammalsModelingModern ManMolecularMolecular InteractionMolecular TargetMurineMusN-terminalNH2-terminalNational Institutes of HealthOrganellesOutcome AssessmentPathway interactionsPatient outcomePatient-Centered OutcomesPatient-Focused OutcomesPatientsPb elementPermeabilityPersonsPhosphatidesPhospholipidsPhosphorylationPhosphotransferase GenePhosphotransferasesPhysiciansPhysiologyPhysiopathologyPlasma MembranePost-Translational Modification Protein/Amino Acid BiochemistryPost-Translational ModificationsPost-Translational Protein ModificationPost-Translational Protein ProcessingPosttranslational ModificationsPosttranslational Protein ProcessingPre-Clinical ModelPreclinical ModelsPredispositionPreparationPrincipal InvestigatorProductionPropertyProtein BindingProtein BiosynthesisProtein ModificationProtein PhosphorylationProtein SecretionProtein-Tyrosine Kinase CYLProteinsPublicationsPulmonary SurfactantsResearchResearch PersonnelResearchersRespiratory FailureRibosomal Peptide BiosynthesisRibosomal Protein BiosynthesisRibosomal Protein SynthesisRoleSARS-CoV-2 epidemicSARS-CoV-2 global health crisisSARS-CoV-2 global pandemicSARS-CoV-2 pandemicSARS-coronavirus-2 epidemicSARS-coronavirus-2 pandemicScientific PublicationScientistSeriesSevere Acute Respiratory Syndrome CoV 2 epidemicSevere Acute Respiratory Syndrome CoV 2 pandemicSevere acute respiratory syndrome coronavirus 2 epidemicSevere acute respiratory syndrome coronavirus 2 pandemicShock LungSiteStiff lungStressStretchingStructureSurface TensionSusceptibilityTimeTrainingTraining SupportTransphosphorylasesTyrosineTyrosine-Protein Kinase CSKUnited States National Institutes of HealthVentilatorVentilator-induced lung injuryVolutraumaWorkWorkshopWritingalveolar lamellar bodyatelectraumabacteria pneumoniabound proteinc-src Kinasec-src Tyrosine Kinasecarboxy-terminal Src kinasecareercareer developmentcell culturecell culturescell sortingcell typechip modelchip systemconferenceconventioncoronavirus disease 2019 crisiscoronavirus disease 2019 epidemiccoronavirus disease 2019 global health crisiscoronavirus disease 2019 global pandemiccoronavirus disease 2019 health crisiscoronavirus disease 2019 pandemiccoronavirus disease 2019 public health crisiscoronavirus disease crisiscoronavirus disease epidemiccoronavirus disease pandemiccoronavirus disease-19 global pandemiccoronavirus disease-19 pandemiccytokinefabricationgene modificationgenetically modifiedheavy metal Pbheavy metal leadimproved outcomeinhibitorinjurieslung functionlung injurymechanical respiratory assistmechanically ventilatedmolecular targeted therapeuticsmolecular targeted therapiesmolecular targeted treatmentmortality ratemouse modelmurine modelmutantnew drug targetnew druggable targetnew pharmacotherapy targetnew therapeutic targetnew therapy targetnovelnovel drug targetnovel druggable targetnovel pharmacotherapy targetnovel therapeutic targetnovel therapy targeton a chipon chipoverexpressoverexpressionpathophysiologypathwaypatient oriented outcomespharmacologicplasmalemmapre-clinicalpreclinicalpreparationspreventpreventingprotein synthesisprotein-tyrosine kinase C-terminal Src kinaseprotein-tyrosine kinase c-srcpulmonary damagepulmonary functionpulmonary injurypulmonary tissue damagepulmonary tissue injurysevere acute respiratory syndrome coronavirus 2 global health crisissevere acute respiratory syndrome coronavirus 2 global pandemicskillssocial rolesrc Kinasessrc Protein-Tyrosine Kinasessrc Tyrosine Kinasessrc-Family Kinasessrc-Family Tyrosine Kinasessummitsurfactantsurfactant functionsymposiasymposiumtherapeutic targetventilation induced lung injuryventilator associated lung injurywet lung
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Full Description

ABSTRACT
Acute respiratory distress syndrome (ARDS) causes respiratory failure, affects more than 200,000

people annually, and has a mortality rate approaching forty percent. There are no molecularly targeted

treatments for ARDS and clinicians utilize life-support with mechanical ventilation (MV) to give patients time to

recover. Although lifesaving, MV can cause injury known as ventilator-induced lung injury (VILI). One

mechanism by which MV induces VILI is through pulmonary surfactant dysfunction. We have identified a

protein, annexin A2 (AnxA2), that is phosphorylated during VILI and is known to play a role in surfactant

release. We hypothesize that injurious forces during VILI lead to phosphorylation of AnxA2 and impaired

surfactant function by inhibiting actin bundling at the site of lamellar body fusion in alveolar type 2 (AT2)

epithelial cells. Aim 1 will define the mechanism by which AnxA2 phosphorylation impairs surfactant function

using a murine pre-clinical ARDS model. Aim 2 will determine how AnxA2 phosphorylation regulates surfactant

release from AT2 cells using a novel, human ventilator-on-a-chip device. The scientific goal of this proposal is

to identify novel molecular targets to treat or prevent surfactant dysfunction during ARDS and ameliorate the

harmful effects of MV in critically ill patients. The research approach has been structured to support a training

plan that will provide training for the principal investigator (Dr. Bentley) in several skills, including (1) becoming

proficient in the fabrication and use of microscale models of the alveolar micro-environment and primary

human lung cell isolation and culture, (2) the generation and use of cell-specific genetically modified mice, and

(3) gaining expertise in murine models of lung injury. Additionally, Dr. Bentley will participate in didactic

courses, workshops, and national conferences to build skills in grant writing and networking. The proposed

work will also support the preparation and submission of 1-2 first-author manuscripts to build a publication

portfolio. The training plan and mentorship committee assembled in this proposal will assist the principle

investigator (Dr. Bentley) in attaining the skills and mentorship necessary to submit a competitive NIH career

development (K-series) award at the end of the award period. Taken together, this proposal will assist the PI in

attaining his goal of becoming an independent physician-scientist with expertise in acute lung injury.

Grant Number: 5F32HL176082-02
NIH Institute/Center: NIH

Principal Investigator: Ian Bentley

Sign up free to get the apply link, save to pipeline, and set email alerts.

Sign up free →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →